In the dynamic landscape of the healthcare sector, SCHOTT PHARMA AG & CO KGAA stands out as a pivotal player, particularly in the realm of drug containment and delivery solutions. Based in Mainz, Germany, this company has carved a niche for itself by offering an array of specialized products and services that cater to the intricate needs of pharmaceutical companies, biotechnology firms, and Contract Development and Manufacturing Organizations (CDMOs) across the globe.
As of August 6, 2026, SCHOTT Pharma’s financial metrics reflect a company that is not only resilient but also poised for growth. The company’s shares, traded on the Xetra stock exchange, closed at 22.15 EUR on August 4, 2026. This figure is a testament to the company’s recovery and growth trajectory, especially when juxtaposed against the 52-week low of 12.62 EUR recorded on March 22, 2026. The 52-week high of 25.1 EUR, achieved on August 10, 2025, underscores the company’s potential and the market’s confidence in its strategic direction.
With a market capitalization of 3.36 billion EUR, SCHOTT Pharma’s valuation is a clear indicator of its significant role in the healthcare sector. The company’s price-to-earnings ratio of 17.38 further highlights its profitability and the market’s positive outlook on its future earnings potential.
At the core of SCHOTT Pharma’s offerings are its prefillable syringes, cartridges, vials, and ampoules. These products are not merely containers; they are sophisticated solutions designed to meet the stringent requirements of drug containment and delivery. The company’s expertise extends beyond manufacturing to include analytical, development, fill-and-finish, and regulatory services. This comprehensive suite of services ensures that SCHOTT Pharma’s clients receive end-to-end solutions that are critical for the successful development and distribution of pharmaceutical products.
SCHOTT Pharma’s global reach is facilitated by its robust online presence, accessible through its website at www.schott-pharma.com . This platform serves as a gateway for clients worldwide to explore and engage with the company’s offerings, underscoring SCHOTT Pharma’s commitment to accessibility and customer service.
In conclusion, SCHOTT PHARMA AG & CO KGAA exemplifies innovation and excellence in the healthcare sector. Its strategic focus on drug containment and delivery solutions, coupled with a strong financial foundation and a global customer base, positions the company as a leader in its field. As the healthcare industry continues to evolve, SCHOTT Pharma’s role in shaping the future of pharmaceutical development and distribution remains both significant and indispensable.
